Institutional Manager · CIK 0001816307
SILVERARC CAPITAL MANAGEMENT, LLC
BOSTON, MA · File #028-21010
Latest AUM
$720.1M
Positions
68
Top-10 Concentration
51.7%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | AVIDITY BIOSCIENCES INC | 05370A108 | -844,633 | -$36.8M | $0 |
| EXITED | AKERO THERAPEUTICS INC | 00973Y108 | -643,636 | -$30.6M | $0 |
| ADD | CELCUITY INC | CELC | +286,446 | +$28.6M | +$4.5M |
| EXITED | UNITED THERAPEUTICS CORP DEL | 91307C952 | -59,900 | -$25.1M | $0 |
| REDUCE | RHYTHM PHARMACEUTICALS INC | RYTM | -234,046 | -$25.1M | +$2.2M |
| NEW | IMMUNOME INC | IMNM | +1,126,210 | +$24.2M | $0 |
| REDUCE | INSMED INC | INSM | -135,392 | -$23.6M | +$6.2M |
| EXITED | CIDARA THERAPEUTICS INC | 171757206 | -220,902 | -$21.2M | $0 |
| REDUCE | OLEMA PHARMACEUTICALS INC | OLMA | -727,261 | -$18.2M | +$14.2M |
| NEW | UNIQURE NV | QURE | +720,800 | +$17.2M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202568 pos · $720.1M
- 13F HOLDINGS REPORTQ/E Sep 202582 pos · $741.6M
- 13F HOLDINGS REPORTQ/E Jun 202565 pos · $542.3M
- 13F HOLDINGS REPORTQ/E Mar 202569 pos · $489.0M
- 13F HOLDINGS REPORTQ/E Dec 202461 pos · $457.2M
- 13F HOLDINGS REPORTQ/E Sep 202471 pos · $445.3M
- 13F HOLDINGS REPORTQ/E Jun 202470 pos · $423.9M
- 13F HOLDINGS REPORTQ/E Mar 202477 pos · $360.1M
- 13F HOLDINGS REPORTQ/E Dec 202380 pos · $329.8M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 422,193 | $56.9M | 8.22% |
| 2 | COGENT BIOSCIENCES INC | COGT | 1,245,254 | $44.2M | 6.39% |
| 3 | UROGEN PHARMA LTD | URGN | 1,738,821 | $40.7M | 5.88% |
| 4 | KALVISTA PHARMACEUTICALS INC | KALV | 2,427,118 | $39.2M | 5.66% |
| 5 | CELCUITY INC | CELC | 375,132 | $37.4M | 5.40% |
| 6 | NUVALENT INC | NUVL | 311,430 | $31.3M | 4.52% |
| 7 | DIANTHUS THERAPEUTICS INC | DNTH | 750,136 | $30.9M | 4.46% |
| 8 | KODIAK SCIENCES INC | KOD | 1,023,122 | $28.6M | 4.13% |
| 9 | PRAXIS PRECISION MEDICINES I | PRAX | 82,465 | $24.3M | 3.51% |
| 10 | IMMUNOME INC | IMNM | 1,126,210 | $24.2M | 3.49% |
| 11 | FRACTYL HEALTH INC | GUTS | 9,840,041 | $21.6M | 3.13% |
| 12 | UNIQURE NV | QURE | 720,800 | $17.2M | 2.49% |
| 13 | MONTE ROSA THERAPEUTICS INC | GLUE | 1,029,066 | $16.1M | 2.33% |
| 14 | VERACYTE INC | VCYT | 357,558 | $15.1M | 2.17% |
| 15 | CG ONCOLOGY INC | CGON | 361,158 | $15.0M | 2.17% |
| 16 | RHYTHM PHARMACEUTICALS INC | RYTM | 135,950 | $14.6M | 2.10% |
| 17 | SYNDAX PHARMACEUTICALS INC | SNDX | 642,899 | $13.5M | 1.95% |
| 18 | BIOGEN INC | BIIB | 75,412 | $13.3M | 1.92% |
| 19 | INSMED INC | INSM | 71,256 | $12.4M | 1.79% |
| 20 | CENTESSA PHARMACEUTICALS PLC | CNTA | 458,203 | $11.5M | 1.65% |